Altimmune Inc (ALT)
4.175
-0.06
(-1.30%)
USD |
NASDAQ |
Apr 10, 15:22
Altimmune Enterprise Value: 193.88M for April 9, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Viking Therapeutics Inc | 1.690B |
| Eli Lilly and Co | 707.26B |
| Amgen Inc | 204.50B |
| Terns Pharmaceuticals Inc | -157.38M |
| Pfizer Inc | 170.92B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.18M |
| Revenue (Quarterly) | 0.005M |
| Total Expenses (Quarterly) | 24.87M |
| EPS Diluted (Quarterly) | -0.33 |
| Profit Margin (Quarterly) | -463.6K% |
| Earnings Yield | -32.10% |
| Normalized Earnings Yield | -32.10 |